Gilead CEO Takes Turn on House Hot Seat

Drug Industry Daily
A A
Gilead CEO Daniel O’Day on Thursday defended his company’s handling of its blockbuster HIV prevention pill Truvada before hostile House Democrats.

To View This Article:

Login

Subscribe To Drug Industry Daily